MiMedx Group, Inc. Long-Term Debt, Maturity, Year One
MiMedx Group, Inc. (MDXG) had Long-Term Debt, Maturity, Year One of $1.50 million as of 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths · last filed 2026-02-25
- 2025-12-31: Long-Term Debt, Maturity, Year One $1.50M.
- 2024-12-31: Long-Term Debt, Maturity, Year One $1.00M.
- 2023-12-31: Long-Term Debt, Maturity, Year One $1.00M.
- 2023-09-30: Long-Term Debt, Maturity, Year One $0.00.
| Period end | Long-Term Debt, Maturity, Year One |
|---|---|
| 2025-12-31 | $1.50M 10-K · filed 2026-02-25 |
| 2024-12-31 | $1.00M 10-K · filed 2025-02-26 |
| 2023-12-31 | $1.00M 10-K · filed 2024-02-28 |
| 2023-09-30 | $0.00 10-Q · filed 2023-10-30 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-01 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-02 |
| 2022-12-31 | $0.00 10-K · filed 2023-02-28 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-02 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-02 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-03 |
| 2021-12-31 | $0.00 10-K · filed 2022-02-28 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-02 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-03 |
| 2021-03-31 | $0.00 10-Q · filed 2021-04-28 |
| 2020-12-31 | $0.00 10-K · filed 2021-03-08 |
| 2019-12-31 | $3.75M 10-K · filed 2020-07-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |